Ablation for heart rhythm problems using a specific technology
Part of Heart & circulation clinical trials.
This study looks at how well catheter ablation works for treating certain heart rhythm disorders (like atrial fibrillation or ventricular arrhythmias) using a specific brand of catheters. The aim is to gather real-world data to better understand the procedure's outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have a type of irregular heartbeat that comes and goes (paroxysmal atrial fibrillation) or lasts more than a week but less than a year (persistent atrial fibrillation), or a ventricular arrhythmia that can be treated with ablation.
- Your doctor has decided that catheter ablation is a good option for you.
- You are willing to be treated with the Biosense Webster catheters during ablation.
- You are able to attend follow-up visits and evaluations.
- You are not currently enrolled in any other clinical trial that would change your treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This trial tests a newer, possibly safer way to treat persistent atrial fibrillation using pulsed field ablation. It compares standard vein isolation alone to adding extra ablation spots to improve success.
This study tests a new way to perform ablation (a type of heart procedure) for people with persistent atrial fibrillation (AF) that hasn't responded well to medication. The goal is to see if a targeted approach to the left atrium's back wall works better than standard ablation.
This study tests a heart rhythm procedure that uses electrical mapping to guide ablation (controlled scarring) of a specific area in the heart's left upper chamber to treat persistent atrial fibrillation—a condition where the heart beats irregularly for more than a week at a time. The goal is to see if this targeted approach helps restore normal heart rhythm.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
Hear when a new Paroxysmal Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.